When can personal best peak flow be determined for asthma action plans?

Background: Written asthma action plans based on personal best peak expiratory flow (PEF) consistently improve health outcomes, whereas those based on predicted PEF do not. Guidelines state that personal best PEF should be assessed over 2–3 weeks during good asthma control, but it is unclear how long to wait after commencing or changing treatment. Methods: Electronically recorded spirometric data from 61 subjects with initially poorly controlled asthma from a 72 week budesonide study were analysed. For each week, average morning pre-bronchodilator PEF was calculated and personal best PEF was determined as the highest PEF in the previous 2 weeks. The time to plateau was defined as the week beyond which no further improvement occurred. Results: At baseline, average morning PEF was 61% predicted and personal best PEF was 87% predicted. Personal best PEF from twice daily monitoring increased to a plateau of 95% predicted (p<0.0001) after only 3 weeks of budesonide treatment. However, average morning PEF continued to improve for 3 months and “as needed” reliever use for 7 months. Conclusions: Personal best PEF is a useful concept for asthma self-management plans when determined as the highest PEF over the previous 2 weeks. With twice daily monitoring, personal best PEF reaches plateau levels after only a few weeks of corticosteroid treatment.

[1]  P. Gibson,et al.  Written action plans for asthma: an evidence-based review of the key components , 2004, Thorax.

[2]  A. Tattersfield,et al.  Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide , 2003, Thorax.

[3]  R. Adams,et al.  Prevalence of asthma and asthma action plans in South Australia: population surveys from 1990 to 2001 , 2003, The Medical journal of Australia.

[4]  M J Hensley,et al.  Self-management education and regular practitioner review for adults with asthma. , 2002, The Cochrane database of systematic reviews.

[5]  Inaccuracy of “Personal Best” Peak Expiratory Flow Rate Reported by Inner-City Patients with Acute Asthma , 2001, The Journal of asthma : official journal of the Association for the Care of Asthma.

[6]  C. Jenkins,et al.  Optimal asthma control, starting with high doses of inhaled budesonide. , 2000, The European respiratory journal.

[7]  A. Bauman,et al.  Self-management education and regular practitioner review for adults with asthma. , 2000, The Cochrane database of systematic reviews.

[8]  Christine Jenkins,et al.  Differences between asthma exacerbations and poor asthma control , 1999, The Lancet.

[9]  C. Jenkins,et al.  Pitfalls in processing home electronic spirometric data in asthma. , 1998, The European respiratory journal.

[10]  Cindy Farquhar,et al.  3 The Cochrane Library , 1996 .

[11]  P. Ind,et al.  Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid , 1994, The Lancet.

[12]  D. Blake,et al.  Patient non-compliance: deviance or reasoned decision-making? , 1992, Social science & medicine.

[13]  M. Lara,et al.  Guidelines For The Diagnosis And Management Of Asthma , 1992, The Journal of the American Board of Family Medicine.

[14]  I Gregg,et al.  New regression equations for predicting peak expiratory flow in adults. , 1989, BMJ.